ICarbonX

Shenzhen, China Founded: 2015 • Age: 11 yrs
Bioinformatics platforms are provided for health management and drug development.
Annual revenue - Latest available
Total funding $365.7M 5 rounds
Employees - Tracked headcount
Investors 6 Known backers
Products - Services tracked
Competitors 8 Brand Intelligence

About ICarbonX

ICarbonX is a company based in Shenzhen (China) founded in 2015 by Yingrui Li, Chun Wu, Hao Li, and Jun Wang. ICarbonX has raised $365.68 million across 5 funding rounds from investors including Tencent, Vcanbio Cell & Gene Engineering Corporation and China Money Network. ICarbonX has completed 1 acquisition, including Imagu. ICarbonX operates in a competitive market with competitors including Strand Life Sciences, Genuity Science, Cellworks, Rhelixa and Codetta, among others.

  • Headquarter Shenzhen, China
  • Founders Yingrui Li, Chun Wu, Hao Li, Jun Wang
  • Stage Unicorn
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $365.68 M (USD)

    in 5 rounds

  • Latest Funding Round
    $151 M (USD), Series D

    Apr 20, 2021

  • Investors
    Tencent

    & 5 more

  • Employee Count
    Not available
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of ICarbonX

Headcount 50-200
Employee Profiles 6
Employee Profiles
People
Leon Yao
Senior IT Director
People
Cynthia Jin 金雯飞
VP of Marketing & Operation
People
Yingrui Li
Co-Founder & Chief Scientist
People
Jun Wang
Founder, CEO & Board Member

Unlock access to complete

Funding Insights of ICarbonX

ICarbonX has successfully raised a total of $365.68M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $151 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in ICarbonX

ICarbonX has secured backing from 6 investors, including institutional investors. Prominent investors backing the company include Tencent, Vcanbio Cell & Gene Engineering Corporation and China Money Network.

All
Institutional
Investor Description Founded Year Domain Location
Investment data and intelligence on Chinese markets are provided.
Locked Locked Locked
Serves as China's sovereign wealth fund, managing strategic investments globally.
Locked Locked Locked
-
Locked Locked Locked
Premium access

Investor details for ICarbonX

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ICarbonX

ICarbonX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Imagu.

Investments
Premium access

Investment portfolio details for ICarbonX

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Object recognition software is developed for multiple industries.
Locked Locked 2005 Locked
Premium access

Complete acquisition details for ICarbonX

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - ICarbonX

Premium access

Detailed financials for ICarbonX

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Icarbonx Comparisons

ICarbonX Primary company
Description
Bioinformatics platforms are provided for health management ...
Location
Shenzhen, China
Founded Year
2015
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for ICarbonX

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ICarbonX

ICarbonX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Strand Life Sciences, Genuity Science, Cellworks, Rhelixa and Codetta, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
Locked Locked Locked
AI-based omics data analysis solutions are provided to researchers.
Locked Locked Locked
Biosimulation platform developed for therapeutic design in life sciences.
Locked Locked Locked
Integrated genomic analysis platform for epigenome data is provided.
Locked Locked Locked
Omics clinical data is analyzed through an online platform.
Premium access

Detailed competitors of ICarbonX

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Icarbonx

Premium access

Complete news archive for ICarbonX

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ICarbonX

ICarbonX was founded in 2015 and raised its 1st funding round 1 year after it was founded.

ICarbonX is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.

Jun Wang is the current CEO of ICarbonX. They have also founded this company.

ICarbonX is a funded company, having raised a total of $365.68M across 5 funding rounds to date.

iCarbonX was founded in 2015 in Shenzhen, China, focusing on bioinformatics for health management and drug development. Big data and artificial intelligence are utilized to analyze omic data alongside phenotypic, social, and environmental information. This analysis supports individual health management and pharmaceutical drug development. Key solutions include the Hey me platform for genetic testing, sports tracking, and personalized plans; the Healthtell immune response chip; and DigitalMe for chronic disease monitoring.

ICarbonX's top competitors include Strand Life Sciences, Cellworks and Rhelixa.

ICarbonX has made 1 acquisition, including Imagu.

ICarbonX has 6 investors. Key investors include Tencent, Vcanbio Cell & Gene Engineering Corporation, China Money Network, China Investment Corporation, and Wealthking Investments.

The valuation of ICarbonX is $1B as of Apr 2016.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available